ADAPTHEALTH CORP (AHCO)
Health Care · Home medical equipment and services / Healthcare-at-home · NASDAQ
AdaptHealth delivers home medical equipment, supplies, and chronic disease management services directly to patients, focusing on sleep apnea, respiratory diseases, diabetes, and post-acute recovery.
What ADAPTHEALTH CORP does
AdaptHealth Corp. is a national provider of patient-centered healthcare-at-home solutions, delivering home medical equipment (HME), medical supplies, and related services directly to patients' homes. The company operates through four segments: Sleep Health (CPAP/BiLevel therapy), Respiratory Health (oxygen and mechanical ventilation), Diabetes Health (continuous glucose monitors and insulin pumps), and Wellness at Home (post-discharge medical supplies and durable equipment). AdaptHealth services approximately 4.3 million patients annually across all 50 states through a network of approximately 640 locations, with revenue streams from resupply/one-time sales (63%), fixed monthly HME rental payments (33%), and at-risk capitation arrangements (4%).
Themes: ["Sleep apnea therapy (CPAP/BiLevel)","Respiratory disease management (COPD/chronic respiratory failure)","Diabetes medical devices and management","Home-based chronic disease management","Post-acute care discharge services","Healthcare-at-home delivery model","Medical equipment rental and resupply","Patient-centered care coordination"]
Fundamentals
- Price$10.16 as of 2026-07-09 close
- Market cap$1.4B as of 2026-07-10
- 1-year return+4.8% as of 2026-07-09 close
- Net margin-2.4% as of 2026-07-10
- Gross margin+20.6% as of 2026-07-10
- ROE-5.1% as of 2026-07-10
- Debt / equity1.24 as of 2026-07-10
- Revenue growth (YoY)+1.2% as of 2026-07-10
- Revenue CAGR (3y)+3.0% SEC XBRL
- Beta1.47 as of 2026-07-10
Key risks (from latest filing)
["Revenue growth remains minimal (1.24% YoY) and the company is unprofitable with a negative net margin of -2.42%, creating pressure on operational leverage and cash flow.","Heavy reliance on Medicare and Medicaid reimbursement with regulatory exposure to CMS rate changes and healthcare policy shifts that could impact fixed monthly HME payments and capitation arrangements.","Significant goodwill and intangible asset burden ($2.6B goodwill on $4.4B total assets) creates substantial impairment risk if operating performance deteriorates or acquisition synergies fail to materialize."]
Competitors & peers
- Amedisys (AMED)
- LHC Group (LHCG)
- Encompass Health (EHC)
- CareCentrix
- DexCom (DXCM)
- ResMed (RMD)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.